PL208543A1 - Sposob wytwarzania nowych imidazoizochinolinodionow - Google Patents

Sposob wytwarzania nowych imidazoizochinolinodionow

Info

Publication number
PL208543A1
PL208543A1 PL20854378A PL20854378A PL208543A1 PL 208543 A1 PL208543 A1 PL 208543A1 PL 20854378 A PL20854378 A PL 20854378A PL 20854378 A PL20854378 A PL 20854378A PL 208543 A1 PL208543 A1 PL 208543A1
Authority
PL
Poland
Prior art keywords
imidazoizochinolinodiones
manufacturing new
manufacturing
new
new imidazoizochinolinodiones
Prior art date
Application number
PL20854378A
Other languages
English (en)
Other versions
PL110398B1 (en
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772732951 external-priority patent/DE2732951A1/de
Priority claimed from DE2732906A external-priority patent/DE2732906C2/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of PL208543A1 publication Critical patent/PL208543A1/pl
Publication of PL110398B1 publication Critical patent/PL110398B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL1978208543A 1977-07-21 1978-07-20 Method of producing new imidazo-isoquinolinodiones PL110398B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19772732951 DE2732951A1 (de) 1977-07-21 1977-07-21 Neue imidazo-isochinolin-dione
DE2732906A DE2732906C2 (de) 1977-07-21 1977-07-21 In 5-Stellung durch einen Aminoalkylrest substituierte Imidazo-isochinolin-dione, Verfahren zu ihrer Herstellung und Arzneimittel

Publications (2)

Publication Number Publication Date
PL208543A1 true PL208543A1 (pl) 1979-05-21
PL110398B1 PL110398B1 (en) 1980-07-31

Family

ID=25772367

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1978208543A PL110398B1 (en) 1977-07-21 1978-07-20 Method of producing new imidazo-isoquinolinodiones

Country Status (29)

Country Link
US (1) US4176184A (pl)
JP (1) JPS5422400A (pl)
AT (1) AT366383B (pl)
AU (1) AU519769B2 (pl)
BG (1) BG30021A3 (pl)
CA (1) CA1091232A (pl)
CH (1) CH642367A5 (pl)
CS (1) CS204032B2 (pl)
DD (1) DD137933A5 (pl)
DK (1) DK323378A (pl)
ES (4) ES471254A1 (pl)
FI (1) FI64371C (pl)
FR (1) FR2398069A1 (pl)
GB (1) GB2002751B (pl)
GR (1) GR65025B (pl)
HK (1) HK20685A (pl)
HU (1) HU181000B (pl)
IL (1) IL55168A (pl)
IT (1) IT1107653B (pl)
LU (1) LU80001A1 (pl)
NL (1) NL7807760A (pl)
NO (1) NO149314C (pl)
NZ (1) NZ187916A (pl)
PL (1) PL110398B1 (pl)
PT (1) PT68329A (pl)
SE (1) SE441746B (pl)
SG (1) SG185G (pl)
SU (1) SU688129A3 (pl)
YU (1) YU40340B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531678A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JP2558707Y2 (ja) * 1986-06-25 1998-01-14 松下電工 株式会社 蓄積式防排煙受信機
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
DE19918211A1 (de) 1999-04-22 2000-10-26 Basf Ag Cycloalkylsubstituierte Benzimidazole, deren Herstellung und Anwendung
WO2001025238A2 (en) * 1999-10-06 2001-04-12 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic compounds useful as inhibitors of tyrosine kinases
US6506769B2 (en) * 1999-10-06 2003-01-14 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic compounds useful as inhibitors of tyrosine kinases
US6489328B2 (en) 2000-08-11 2002-12-03 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic compounds useful as inhibitors of tyrosine kinases
JP4537407B2 (ja) * 2003-10-30 2010-09-01 ベーリンガー インゲルハイム (カナダ) リミテッド Rsvポリメラーゼインヒビター

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE368009B (pl) * 1971-09-16 1974-06-17 Kabi Ab
US3919238A (en) * 1973-06-06 1975-11-11 Morton Norwich Products Inc 9-(Substituted amino)imidazo(4,5-f) quinolines
US3878206A (en) * 1973-06-06 1975-04-15 Morton Norwich Products Inc 9-(Substituted amino)imidazo{8 4,5-f{9 quinolines

Also Published As

Publication number Publication date
GR65025B (en) 1980-06-16
CS204032B2 (en) 1981-03-31
HK20685A (en) 1985-03-29
SG185G (en) 1985-06-14
GB2002751B (en) 1982-02-10
SE441746B (sv) 1985-11-04
FI782011A (fi) 1979-01-22
IL55168A (en) 1981-09-13
DK323378A (da) 1979-01-22
US4176184A (en) 1979-11-27
YU174778A (en) 1983-02-28
HU181000B (en) 1983-05-30
NO149314B (no) 1983-12-19
CA1091232A (en) 1980-12-09
FI64371C (fi) 1983-11-10
SE7808018L (sv) 1979-01-22
FR2398069B1 (pl) 1981-05-22
CH642367A5 (de) 1984-04-13
LU80001A1 (de) 1979-09-06
PT68329A (de) 1978-08-01
JPS6112912B2 (pl) 1986-04-10
AU519769B2 (en) 1981-12-24
BG30021A3 (en) 1981-03-16
NL7807760A (nl) 1979-01-23
PL110398B1 (en) 1980-07-31
IT1107653B (it) 1985-11-25
IL55168A0 (en) 1978-09-29
AU3821078A (en) 1980-01-24
NO149314C (no) 1984-03-28
AT366383B (de) 1982-04-13
YU40340B (en) 1985-12-31
ATA498878A (de) 1981-08-15
ES476168A1 (es) 1979-05-16
FR2398069A1 (fr) 1979-02-16
ES476167A1 (es) 1979-04-16
NO782498L (no) 1979-01-23
ES476166A1 (es) 1979-06-01
DD137933A5 (de) 1979-10-03
ES471254A1 (es) 1979-10-01
SU688129A3 (ru) 1979-09-25
IT7850337A0 (it) 1978-07-17
FI64371B (fi) 1983-07-29
NZ187916A (en) 1981-05-01
GB2002751A (en) 1979-02-28
JPS5422400A (en) 1979-02-20

Similar Documents

Publication Publication Date Title
PL205287A1 (pl) Sposob wytwarzania nowych 4-acyloaminofenylo-etanoloamin
PL201286A1 (pl) Sposob wytwarzania nowych 1-aryloksy-2-hydroksy-3-alkileno-aminopropanow
PL202305A1 (pl) Sposob wytwarzania furanokumaryny
PL207835A1 (pl) Sposob etylowania monoalkilobenzenu
PL207887A1 (pl) Sposob wytwarzania parabenzochinonu
PL205592A1 (pl) Sposob wytwarzania nitrozobenzenu
PL200534A1 (pl) Sposob wytwarzania nowych oksadeztiacefalosporyn
PL211409A1 (pl) Sposob wytwarzania nowych podstawionych pirolidyn
PL208543A1 (pl) Sposob wytwarzania nowych imidazoizochinolinodionow
PL204428A1 (pl) Sposob wytwarzania nowych pochodnych erytomycyny
PL207592A1 (pl) Sposob wytwarzania nowych pirydazynylohydrazonow
PL104866B1 (pl) Sposob wytwarzania nowych pirydobenzodwuazepinonow
PL209329A1 (pl) Sposob wytwarzania 2-chlorosulfinyloazetydynonow-4
PL211668A1 (pl) Sposob wytwarzania nowych 3-dwu-n-propyloacetoksybenzodiazepinonow-2
PL205590A1 (pl) Sposob wytwarzania 2-hydroksybenzotiazoli
PL198559A1 (pl) Sposob wytwarzania dwu-n-propylo-acetonitrylu
PL210932A1 (pl) Sposob wytwarzania tiolokarbaminianow
PL204964A1 (pl) Sposob wytwarzania akantomycyny
PL204882A1 (pl) Sposob wytwarzania nowych triazolo-tieno-dwuazepinonow-1
PL196842A1 (pl) Sposob wytwarzania nowych zasadowych barwnikow metinowych
PL204509A1 (pl) Sposob wytwarzania nowych dwuwodorobenzopiranoksantenonow
PL201824A1 (pl) Sposob wytwarzania m-benzoiloacetofenonu
PL201626A1 (pl) Sposob wytwarzania trojchlorobenzenow
PL201625A1 (pl) Sposob wytwarzania trojchlorobenzenow
PL198669A1 (pl) Sposob wytwarzania chlorocyjanu